Kiwa Bio-Tech Products Group Corp (fka KWBT)

[operating_line]

Undervalued based on sales levels

1. Sales are at 60% for first half of year, slowed by COVID19.
So how is it looking for the remaining half of the year?

WSJ: China’s Economy Is Bouncing Back
https://www.wsj.com/articles/chinas-economy-is-bouncing-backand-gaining-ground-on-the-u-s-11598280917

and do we see follow up on that sentiment?

China approves BlackRock, Temasek and CCB joint wealth venture
"Top global financial players have long sought to increase their presence in the relatively fast-growing Chinese economy"

https://www.reuters.com/article/us-china-finance-jv/china-approves-blackrock-temasek-and-ccb-joint-wealth-venture-idUSKBN25I0LP


2. Cash management was the apparent problem. They are pulling together additional bank lending. I for one am relieved they are not dealing with more TOXIC NOTES. You can check where the issuers are located.

Recently in China they have agreements with solid institutions:
a. Shaanxi Agricultural Credit Financing Guarantee Co., Ltd. (“SACFG”)
b. Postal Savings Bank of China (“PSBC”)

https://www.globenewswire.com/news-release/2020/04/08/2013408/0/en/Kiwa-Bio-Tech-Announces-100-Million-RMB-Loan-Program-To-Boost-Agriculture-Production-in-China.html

3. I am not interested in the individual entry or exit and rather that the business has a good plan forward. New Chinese investors will help fund the business and support KWBT stock with purchase of "new shares of common stock "

4. We need to see the filings of course but we got an expected date. We need to wait until perhaps November for that, given the Q3 was released then in 2019. Maybe someone else can confirm the expected date.